Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study
Crossref DOI link: https://doi.org/10.1186/bcr3690
Published Online: 2014-07-08
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schneeweiss, Andreas
Chia, Stephen
Hegg, Roberto
Tausch, Christoph
Deb, Rahul
Ratnayake, Jayantha
McNally, Virginia
Ross, Graham
Kiermaier, Astrid
Cortés, Javier
License valid from 2014-07-08